Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M405314200 on July 9, 2004

J. Biol. Chem., Vol. 279, Issue 37, 38903-38911, September 10, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/37/38903    most recent
M405314200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Deb, T. B.
Right arrow Articles by Dickson, R. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Deb, T. B.
Right arrow Articles by Dickson, R. B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calmodulin-mediated Activation of Akt Regulates Survival of c-Myc-overexpressing Mouse Mammary Carcinoma Cells*

Tushar B. Deb, Christine M. Coticchia{ddagger}, and Robert B. Dickson§

From the Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D. C. 20057

c-Myc-overexpressing mammary epithelial cells are proapoptotic; their survival is strongly promoted by epidermal growth factor (EGF). We now demonstrate that EGF-induced Akt activation and survival in transgenic mouse mammary tumor virus-c-Myc mouse mammary carcinoma cells are both calcium/calmodulin-dependent. Akt activation is abolished by the phospholipase C-{gamma} inhibitor U-73122, by the intracellular calcium chelator BAPTA-AM, and by the specific calmodulin antagonist W-7. These results implicate calcium/calmodulin in the activation of Akt in these cells. In addition, Akt activation by serum and insulin is also inhibited by W-7. EGF-induced and calcium/calmodulin-mediated Akt activation occurs in both tumorigenic and non-tumorigenic mouse and human mammary epithelial cells, independent of their overexpression of c-Myc. These results imply that calcium/calmodulin may be a common regulator of Akt activation, irrespective of upstream receptor activator, mammalian species, and transformation status in mammary epithelial cells. However, only c-Myc-overexpressing mouse mammary carcinoma cells (but not normal mouse mammary epithelial cells) undergo apoptosis in the presence of the calmodulin antagonist W-7, indicating the vital selective role of calmodulin for survival of these cells. Calcium/calmodulin-regulated Akt activation is mediated directly by neither calmodulin kinases nor phosphatidylinositol 3-kinase (PI-3 kinase). Pharmacological inhibitors of calmodulin kinase kinase and calmodulin kinases II and III do not inhibit EGF-induced Akt activation, and calmodulin antagonist W-7 does not inhibit phosphotyrosine-associated PI-3 kinase activation. Akt is, however, co-immunoprecipitated with calmodulin in an EGF-dependent manner, which is inhibited by calmodulin antagonist W-7. We conclude that calmodulin may serve a vital regulatory function to direct the localization of Akt to the plasma membrane for its activation by PI-3 kinase.


Received for publication, May 12, 2004 , and in revised form, July 7, 2004.

* This work was supported in part by National Institutes of Health Grant R01-CA72460 and United States Department of Defense Grant DAMD 17-01-1-0251 (to R. B. D.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

{ddagger} Supported by a predoctoral training grant from the United States Department of Defense (DAMD 17-01-1-0246).

§ To whom correspondence should be addressed: Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, New Research Building, Room W417, 3970 Reservoir Road NW, Washington, D.C. 20057. Tel.: 202-687-3770; Fax: 202-687-7505; E-mail: dicksonr{at}georgetown.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Circ. Res.Home page
X. Hu, X. Xu, Y. Huang, J. Fassett, T. P. Flagg, Y. Zhang, C. G. Nichols, R. J. Bache, and Y. Chen
Disruption of Sarcolemmal ATP-Sensitive Potassium Channel Activity Impairs the Cardiac Response to Systolic Overload
Circ. Res., October 24, 2008; 103(9): 1009 - 1017.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
T. Pisitkun, V. Jacob, S. M. Schleicher, C.-L. Chou, M.-J. Yu, and M. A. Knepper
Akt and ERK1/2 pathways are components of the vasopressin signaling network in rat native IMCD
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1030 - F1043.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
T. B. Deb, C. M. Coticchia, R. Barndt, H. Zuo, R. B. Dickson, and M. D. Johnson
Pregnancy-upregulated nonubiquitous calmodulin kinase induces ligand-independent EGFR degradation
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C365 - C377.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Dong, C. A. Valencia, and R. Liu
Ca2+/Calmodulin Directly Interacts with the Pleckstrin Homology Domain of AKT1
J. Biol. Chem., August 24, 2007; 282(34): 25131 - 25140.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
Y. Wang, J. Wu, and Z. Wang
Akt Binds to and Phosphorylates Phospholipase C-{gamma}1 in Response to Epidermal Growth Factor
Mol. Biol. Cell, May 1, 2006; 17(5): 2267 - 2277.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. Maslowska, H. Legakis, F. Assadi, and K. Cianflone
Targeting the signaling pathway of acylation stimulating protein
J. Lipid Res., March 1, 2006; 47(3): 643 - 652.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X. Shen, C. A. Valencia, J. W. Szostak, B. Dong, and R. Liu
Scanning the human proteome for calmodulin-binding proteins
PNAS, April 26, 2005; 102(17): 5969 - 5974.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement